소아용 백신 시장 : 기술, 백신, 적응증, 최종사용자별 - 세계 예측(2025-2030년)

The Pediatric Vaccines Market was valued at USD 19.07 billion in 2023, expected to reach USD 21.26 billion in 2024, and is projected to grow at a CAGR of 11.57%, to USD 41.06 billion by 2030.

The pediatric vaccines market encompasses a broad scope, targeting the immunization needs of children from infancy through adolescence. Modern pediatric vaccines are designed to protect against a variety of infectious diseases, including measles, mumps, rubella, polio, influenza, and chickenpox, among others. The necessity of these vaccines is underscored by the objective of achieving herd immunity and preventing outbreaks, which is critical for public health. They find applications in public and private healthcare settings, including clinics, hospitals, and pharmacy-based immunization centers, catering to both routine immunization schedules and special vaccination campaigns.

The market is primarily driven by increased awareness of the benefits of immunization, government mandates, and global health initiatives from organizations such as WHO and UNICEF. Boosting factors include advancements in vaccine technology, public-private partnerships, and rising incidence of contagious diseases in children. Additionally, growing investments in R&D efforts for novel vaccine development provide lucrative opportunities, especially with the emergence of mRNA technologies. However, market growth is challenged by vaccine hesitancy, supply chain disruptions, high costs of development, and stringent regulatory requirements, which can impede the introduction of new vaccines.

To seize potential opportunities, companies should focus on innovations in delivery methods, such as needle-free technologies, and explore the extension of vaccine protection durations. Emphasizing digital health integration can help enhance vaccine tracking and coverage efficiency. Addressing challenges, fostering effective communication strategies to combat misinformation, and fostering collaborations for expanding access in emerging markets can facilitate market expansion. Continued research into combination vaccines and better cold chain logistics are pivotal areas for business growth. The pediatric vaccines market is dynamic, characterized by rapid technological evolution, regulatory scrutiny, and operational complexities, yet it offers vast potential for innovation and expansion for firms that navigate these challenges adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Vaccines Market

The Pediatric Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious diseases in the pediatric population
  • Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
  • Government intervention for the use of pediatric vaccines
• Market Restraints
  • Lack of implementation of mandatory vaccination
  • Slight-side effects associated with pediatric vaccines
• Market Opportunities
  • Strong late-stage pipeline and new drug approvals
  • Routinized vaccines used in immunization of infants and children
• Market Challenges
  • No uniform recall or reminder system and staff shortages

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Vaccines Market

A detailed market share analysis in the Pediatric Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Vaccines Market

A strategic analysis of the Pediatric Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Vaccines Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., SINOVAC Biotech Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
• Based on Vaccine, market is studied across Monovalent and Multivalent.
• Based on Indication, market is studied across Haemophilus Influenzae Type B, Hepatitis, Human Papillomavirus , Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
• Based on End User, market is studied across Hospital, Pediatric Clinic, and Research Organization.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
    • 5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
    • 5.1.1.3. Government intervention for the use of pediatric vaccines
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of implementation of mandatory vaccination
    • 5.1.2.2. Slight-side effects associated with pediatric vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Strong late-stage pipeline and new drug approvals
    • 5.1.3.2. Routinized vaccines used in immunization of infants and children
  • 5.1.4. Challenges
    • 5.1.4.1. No uniform recall or reminder system and staff shortages
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pediatric Vaccines Market, by Technology

• 6.1. Introduction
• 6.2. Attenuated Live Viruses
• 6.3. Conjugates
• 6.4. Inactivated Viruses
• 6.5. Polysaccharides
• 6.6. Recombinant
• 6.7. Subunits
• 6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine

• 7.1. Introduction
• 7.2. Monovalent
• 7.3. Multivalent

8. Pediatric Vaccines Market, by Indication

• 8.1. Introduction
• 8.2. Haemophilus Influenzae Type B
• 8.3. Hepatitis
• 8.4. Human Papillomavirus
• 8.5. Measles
• 8.6. Meningitis A
• 8.7. Mumps
• 8.8. Pneumococcal Diseases
• 8.9. Polio
• 8.10. Rotaviruses
• 8.11. Rubella
• 8.12. Tetanus
• 8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User

• 9.1. Introduction
• 9.2. Hospital
• 9.3. Pediatric Clinic
• 9.4. Research Organization

10. Americas Pediatric Vaccines Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pediatric Vaccines Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pediatric Vaccines Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca PLC
• 2. Bavarian Nordic A/S
• 3. CSL Limited
• 4. Eli Lilly and Company
• 5. GlaxoSmithKline PLC
• 6. Indian Immunologicals Ltd.
• 7. Johnson & Johnson Services, Inc.
• 8. Merck & Co., Inc.
• 9. Mitsubishi Chemical Corporation
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Sanofi S.A.
• 13. Serum Institute of India Pvt. Ltd.
• 14. SINOVAC Biotech Ltd.
• 15. Zoetis Inc.